雄性猕猴血清中促黄体素的分泌水平

本文采用促黄体素（ＬＨ）体外生物测定法，对不同年龄组雄性猴血清中促黄体素分泌水平进行了分析。结果表明：幼年组为５．４±１．７ｎｇ／ｍｌ，成年组为４５．６±１２．８ｎｇ／ｍｌ，老年组为６９．２±２１．５ｎｇ／ｍｌ。提示雄性猕猴ＬＨ分泌模式与人很相似。     

多巴胺、雌二醇及睾酮对虎纹蛙离体脑垂体促性腺激素分泌的影响

为了解虎纹蛙促性腺激素分泌的调节机理,用离体静态培育系统和放射免疫测定法,研究了多巴胺（ＤＡ）、雌二醇（Ｅ２）和睾酮（Ｔ）对雌性虎纹蛙离体脑垂体薄片促黄体激素（ＬＨ）和促卵泡激素（ＦＳＨ）分泌活动的影响。结果表明：０．１～１０μｍｏｌ／Ｌ的ＤＡ对成熟前期和冬眠期虎纹蛙离体脑垂体型薄片的ＬＨ及ＦＳＨ的释放都有抑制作用,并且随着ＤＡ浓度的增加,抑制作用逐渐增强。１和１０μｍｏｌ／Ｌ的Ｅ２显著刺激成熟前     

用ELISA法检测2.5S鼠神经生长因子

鼠颌下腺提纯的２５ＳＮＧＦ免疫家兔,获得兔抗ＮＧＦ抗体,研制出鼠２５ＳＮＧＦＥＬＩＳＡ检测试剂盒,该试剂盒灵敏度小于１ｎｇ／ｍｌ,在６７０～０８４ｎｇ／ｍｌ范围内,线性良好,ｒ＝０９９。与大鼠、小鼠及人血浆无非特异反应,在大鼠血浆中,ＮＧＦ样品回收率在９１％～１０７％之间,变异系数小于１０％（ｎ＝４）。结果表明：本试剂盒操作简便,灵敏度高,特异性强,适合药代动力学研究及生产过程中的ＮＧＦ检测。     

放线菌果胶酶产酶条件及酶促反应条件的研究

从埋麻土壤中分离到放线菌２９８株,经初筛和复筛得到产酶活性较高的一株放线菌５－７１。最适产酶条件是：果胶０．５％,葡萄糖０．５％,蛋白胨０．５％,酵母粉０．１％,Ｋ２ＨＰＯ４ ０．１％,ＫＨ２ＰＯ４ ０．１％,ＮａＣｌ０．１％,ＭｇＳＯ４·７Ｈ２Ｏ０．０５％,ｐＨ８．０。２５℃培养３天达产酶高峰。通气量对产酶影响不大。酶促反应最适条件是：ｐＨ９．６,４５℃,底物果胶浓度０．７５％,作用时间９０ｍｉ     

rhCNTF对鸡胚感觉与运动神经元神经营养作用的比较

在无血清培养条件下,观察了重组人睫状营养因子（ｒｈＣＮＴＦ）对鸡胚背根节感觉神经元及腹角运动神经元的营养作用。结果表明ｒｈＣＮＴＦ对这两类神经元均有明显的促存活作用,并呈一定的剂量／效应关系。ｒｈＣＮＴＦ浓度在０．５ｎｇ／ｍｌ以下时无作用,１．０－１．５ｎｇ／ｍｌ时已有促神经元存活作用,４ｎｇ／ｍｌ时作用最明显,再增加到１００ｎｇ／ｍｌ神经元存活数无进一步增加。比较培养７天时两类神经元存活数发现感觉神经元对ＣＮＴＦ缺乏的敏感性高于运动神经元,提示ＣＮＴＦ对运动神经元的促存活作用只是它多种类型神经元营养作用中较弱的一环     

血小板生长因子(PDGF-BB)刺激体外培养兔肺动脉平滑肌细胞DNA和蛋白质合成

应用细胞培养、３Ｈ－ＴｄＲ和３Ｈ－Ｌｅｕｃｉｎｅ掺入方法,观察血小板生长因子ＢＢ（Ｐｌａｔｅｌｅｔ－ｄｅｒｉｖｅｄＧｒｏｗｔｈＦａｃｔｏｒＢＢ）对体外培养兔肺动脉平滑肌细胞ＤＮＡ和蛋白质合成的影响。结果表明：（１）当ＰＤＧＦ－ＢＢ浓度为１０ｎｇ／ｍｌ时,３Ｈ－ＴｄＲ掺入值已较对照组显著增高（６２６２．５±４１２．９ｖｓ８３３．５±１２４．０,Ｐ＜０．０５）;当ＰＤＧＦ－ＢＢ浓度为２０ｎｇ／ｍｌ时,３Ｈ－Ｌｅｕｃｉｎｅ掺入值亦较对照线显著增高（１０２１２．８±６３８．３ｖｓ７３４０．３±１１９７．９,Ｐ＜０．０５）。（２）ＰＤＧＦ－ＢＢ浓度在５－２５ｎｇ／ｍｌ范围内,３Ｈ－ＴｄＲ,３Ｈ－Ｌｅｕｃｉｎｅ掺入值与剂量直线相关（ｒＤＮＡ＝０．９７,ｒｐｒｏｔ＝０．９０Ｐ＜０．０５）。说明ＰＤＧＦ－ＢＢ刺激体外培养兔肺动脉平滑肌细胞ＤＮＡ和蛋白质合成。     

促性腺激素对猪卵丘细胞-卵母细胞复合体体外减数分裂恢复作用的研究

本实验利用猪卵母细胞体外无血清培养技术,选用猪卵泡液中自然存在的次黄嘌呤（ＨＸ）作为卵母细胞自发成熟的抑制剂,研究了促性腺激素对猪卵丘细胞－卵母细胞复合体（ＣＥＯ）减数分裂恢复的具体作用。ＣＥＯ在含有不同浓度的促性腺激素（ＦＳＨ,ｈＣＧ,ＦＳＨ＋ｈＣＧ）的培养液中培养２４ｈ,观察卵母细胞减数分裂恢复（ＧＶＢＤ）情况。实验结果如下：１．ＦＳＨ（１－５００ＩＵ／Ｌ）能够明显刺激ＣＥＯ克服ＨＸ的抑制作用而恢复减数分裂（Ｐ＜０．０５）,该作用具有剂量依赖性;２．ｈＣＧ（１－５００ＩＵ／Ｌ）对ＣＥＯ减数分裂的恢复无明显作用;３．ｈＣＧ（１０－５００ＩＵ／Ｌ）与ＦＳＨ（１０,１００ＩＵ／Ｌ）无协同作用。上述结果表明,猪ＣＥＯ减数分裂的恢复可能主要依赖于ＦＳＨ的作用,该作用能使猪卵丘细胞产生一种或几种阳性因子,作用于卵母细胞,从而克服ＨＸ的抑制作用而恢复减数分裂。ｈＣＧ无明显作用,可能是因为卵丘细胞上没有ＬＨ受体或ＬＨ受体的数量不足     

血管活性肠肽对清醒大鼠催乳素分泌的影响

在离体研究中发现,血管活性肠肽（ＶＩＰ）对催乳素分泌的促进作用因垂体所取自的动物模型的不同而异。本实验则以不同生理状态的大鼠为动物模型,于清醒自由活动状态下,检验ＶＩＰ的静脉注入对催乳素释放的影响。结果表明,在ＶＩＰ注入后１０ｍｉｎ时,其外周血液的浓度达到最高值（２１３２±２３３）ｎｇ／ｍｌ,并至少持续３０ｍｉｎ。在本实验的所有动物模型中,ＶＩＰ均诱导出了显著的催乳素分泌峰（Ｐ＜００５）,就其提高程度而言,雄性鼠最高（１５８０４±３７０６）ｎｇ／ｍｌ,未经吸吮刺激的哺乳母鼠最低（３１０５±４４２）ｎｇ／ｍｌ,而经过吸吮刺激的哺乳母鼠则居于两者之间（９０１０±３６００）ｎｇ／ｍｌ。ＶＩＰ在不同动物模型中所表现出的这些差异,提示其作用方式和／或作用部位可能受到整个机体内分泌环境和神经刺激的整合。     

内皮素和bFGF对MC的促增殖作用及胰岛素的协同效应

采用３Ｈ－ＴｄＲ参入法,测定碱性成纤维细胞生长因子（ｂＦＧＦ）、胰岛素和内皮素－１（ＥＴ－１）对体外培养的大鼠肾小球系膜细胞（ＭＣ）增殖的影响,以及胰岛素与ｂＦＧＦ或ＥＴ－１促ＭＣ增殖的协同作用。结果表明,不同浓度的ｂＦＧＦ（５－２００ｎｇ／ｍｌ）和胰岛素（０．１－２．４Ｕ／ｍｌ）均显著升高ＭＣ的３Ｈ－ＴｄＲ参入值（ｃｐｍ值）（Ｐ＜０．０１）。ＥＴ－１对ＭＣ的ｃｐｍ值的影响依剂量不同呈现两种不同的效应,在１０－９－１０－７ｍｏｌ／Ｌ时,随着浓度的升高,ＭＣ的ｃｐｍ值明显升高（Ｐ＜０．０１）,并以１０－８ｍｏｌ／Ｌ作用最强;当升高到１０－６ｍｏｌ／Ｌ时,ＭＣ的ｃｐｍ值出现降低趋势。胰岛素与ｂＦＧＦ或低浓度ＥＴ－１（≤１０－８ｍｏｌ／Ｌ）共同作用于ＭＣ时,ＭＣ的ｃｐｍ值明显高于二者单独作用之和（Ｐ＜０．０１）,与高浓度ＥＴ－１（＞１０－７ｍｏｌ／Ｌ）共同作用于ＭＣ时,ＭＣ的ｃｐｍ值小于二者单独作用之和（Ｐ＞０．０５）。上述结果说明,胰岛素、ｂＦＧＦ和ＥＴ－１均能显著促进ＭＣ增殖;胰岛素与ｂＦＧＦ或低浓度的ＥＴ－１促ＭＣ增殖具有正协同作用,与高浓度ＥＴ－１呈现负协同作用。     

人免疫重建SCID小鼠的研究

４２只不渗漏ＳＣＩＤ小鼠分别腹腔注射经冷冻、复苏的胎肝或胎肝加胎胸腺细胞,每鼠２×１０７活细胞,建立人胎肝细胞ＳＣＩＤ小鼠模型Ⅰ和Ⅱ,研究人免疫系统。用人肝癌细胞（ＨＨＣＣ）免疫,ＳＣＩＤ鼠出现初始免疫答应,血清人ＩｇＧ平均滴度分别达到５１３．０±８４．２ｎｇ／ｍｌ和７１９．７±２０１．６ｎｇ／ｍｌ,ＩｇＧ峰值分别出现在免疫重建后１０～１２和１０～１４周,特异性抗ＨＨＣＣ抗体滴度分别达到１∶７０．４±３５．０５和１∶２９４．４±１６８．５２,免疫重建后７～８周龄,ＡＢＣ法免疫组化染色,免疫鼠模型肝、脾中可检出标记人的ＣＤ３＋、ＣＤ２０＋Ｔ和Ｂ淋巴细胞克隆和细胞岛。流式细胞仪检测了抗原免疫组和模型组外周血、脾脏、肝脏的人ＣＤ３＋、ＣＤ４＋、ＣＤ８＋、ＣＤ１９＋、ＣＤ２０＋标记的淋巴细胞数,其中标记ＣＤ２０＋淋巴细胞平均值外周血３．１２±３．０３％、脾脏１．４±０．２０％、肝脏２．３２±１．４９％。而无抗原免疫的模型组在肝脏仅有微量或检测不到人标记淋巴细胞。     

Insulin binding in human skeletal muscle

Insulin binding to crude plasma membranes derived from human skeletal muscle was characterized. Incubations were performed for 22 h at 4°C. Typical insulin binding characteristics were found, i.e., (a) specificity for insulin, (b) pH sensitivity, (c) dissociation of insulin by the addition of excess insulin and (d) concave Scatchard curves. Half-maximal inhibition of ¹²⁵I-labeled-insulin binding occurred at 1 · 10^?8 M. Affinity constants were 0.76 · 10⁹ and 0.02 · 10⁹ M^?1 for the high- and low-affinity receptor (2-site model), respectively, and the corresponding receptor numbers were 89 and 1450 fmol/mg protein, respectively. The procedures employed permit the determination of insulin binding to small quantities of human muscle (approx. 250 mg).     

Tumor necrosis factor inhibits glucocorticoid receptor function in mice: a strong signal toward lethal shock

As glucocorticoid resistance (GCR) and the concomitant burden pose a worldwide problem, there is an urgent need for a more effective glucocorticoid therapy, for which insights into the molecular mechanisms of GCR are essential. In this study, we addressed the hypothesis that TNFα, a strong pro-inflammatory mediator in numerous inflammatory diseases, compromises the protective function of the glucocorticoid receptor (GR) against TNFα-induced lethal inflammation. Indeed, protection of mice by dexamethasone against TNFα lethality was completely abolished when it was administered after TNFα stimulation, indicating compromised GR function upon TNFα challenge. TNFα-induced GCR was further demonstrated by impaired GR-dependent gene expression in the liver. Furthermore, TNFα down-regulates the levels of both GR mRNA and protein. However, this down-regulation seems to occur independently of GC production, as TNFα also resulted in down-regulation of GR levels in adrenalectomized mice. These findings suggest that the decreased amount of GR determines the GR response and outcome of TNFα-induced shock, as supported by our studies with GR heterozygous mice. We propose that by inducing GCR, TNFα inhibits a major brake on inflammation and thereby amplifies the pro-inflammatory response. Our findings might prove helpful in understanding GCR in inflammatory diseases in which TNFα is intimately involved.     

Thyroid hormone: Aldosterone antagonism in cultured epithelial cells

Thyroid hormone (T₃) has been demonstrated to inhibit the action of aldosterone on sodium transport in toad urinary bladder and rat kidney. We have exammined the effect of T₃ on aldosterone action and specific nuclear binding in cultured epithelial cells derived from toad urinary bladder. In cell line TB6-C, addition of 5·10⁻⁸ M T₃ to culture media for up to 3 days results in no change in short-circuit current or transepithelial resistance. This concentration of T₃ completely inhibits the maximal increase in short-circuit current in response to 1·10⁻⁷ M aldosterone. The inhibition can be demonstrated with 18 h preincubation or with simultaneous addition of T₃ and aldosterone. The half-maximal concentration for the inhibition of the aldosterone effect is approx. 5·10⁻⁹ M T₃. T₃ has no effect on cyclic AMP-stimulated short-circuit current in these cells. The effect of T₃ on nuclear binding of [³H]aldosterone was examined using a filtration assay with data analysis by at least-squares curve-fitting program. Best fit was obtained with a model for two binding sites. The dissociation constants for the binding were K′_d1 = (0.82 ± 0.36)·10⁻¹⁰ M and K′_d2 = (3.2±0.60)·10⁻⁸ M.The half-maximal concentration for aldosterone-stimulated sodium transport in these cells is approx. 1·10⁻⁸ M. Analysis of nuclear aldosterone binding in cells preincubated for 18 h with 5·10⁻⁸ M T₃ showed a K′_d1 = (0.15 ± 0.10)·10⁻¹⁰ M and K′_d2 = (3.5 ± 0.10)·10⁻⁸ M. We conclude that T₃ i action of aldosterone on sodium transport at a site after receptor binding in the nucleus.     

Identification of an intracellular pathway of thyroxine synthesis by dispersed thyroid cells

This study deals with the identification of the biochemical events involved in the metabolic sequence leading from the synthesis to the release of thyroxine in the dispersed thyroid cell system. (1) Using an experimental model allowing the differentiation between intracellular and extracellular sites of iodination, it is shown that thyroxine is synthesized inside the cells by an iodinating system sensitive to thyrotropin stimulation. (2) The secretion of thyroxine synthesized inside the cells is not mediated by an exocytotic-endocytotic phenomenon. Colchicine, vinblastine, fluoride, propanolol and chlorpromazine, at concentrations equal to or 10–100-times higher than those required to inhibit hormone release in follicular-organized thyroid tissue have no effect on thyrotropin-stimulated thyroxine secretion. (3) The secretion involves the intracellular proteolysis of hormone-containing iodoprotein(s) which, in addition to free thyroxine, generates free mono- and diiodotyrosines. Free thyroxine is released into the incubation medium and iodotyrosines are deiodinated under normal conditions and accumulate in the presence of an inhibitor of iodotyrosine deiodinase: 3,5-dinitrotyrosine. This proteolysis is inhibited by 5 mM chlorpromazine. These data indicate that the complete metabolic sequence leading from the uptake of iodide to the release of free thyroxine into the incubation medium can be described as an ‘intracellular metabolic sequence for thyroxine synthesis’.     

Ability of growth hormone fragments to compete with I-iodinated human growth hormone for specific binding to isolated adipocytes of hypophysectomized rats

Several noncovalent complexes of large fragments of human GH, which are less active than native human GH in stimulating glucose metabolism in adipose tissue of hypophysectomized rats, were tested for their ability to compete with ¹²⁵I-iodinated human GH for specific binding to isolated adipocytes of hypophysectomized rats. The complexes tested were A (residues 1–134 + residues 141–191; S-carbamidomethylated), B (residues 1–134 + residues 135–191; S-carbamidomethylated) and C (residues 1–134 + residues 135–191; S-carboxymethylated). When compared to native human GH, the complexes were less active in competing with ¹²⁵I-iodinated human GH for specific binding to adipocytes, and their order of potency in the binding assay (A > B > C) was similar to that of their respective activities in stimulating glucose metabolism in isolated adipose tissue of hypophysectomized rats.     

Evidence for a coupling of prolactin secretion and synthesis by rat pituitary cells in culture

The relationship between the release and the synthesis of prolactin by rat pituitary cells in culture was studied using a microtubule-disrupting drug, vinblastine. (1) Prolactin secretion was inhibited by vinblastine in short-term incubations. Vinblastine did not act via the dopamine pathway, since a potent anti-dopaminergic drug, fluphenazine, was unable to reverse the inhibiting action of the antimicrotubular agent. (2) Continuous treatment by vinblastine induced a progressive decrease of the rate of incorporation of [³H]leucine in prolactin. The half-inhibition time was about 2 days. This inhibition of prolactin synthesis was selective, since total protein synthesis remained unaffected. (3) Measurements of radioimmunoassayable prolactin showed that the inhibition of hormone release by vinblastine led to a transient increase of the intracellular content of prolactin. The phase of over-accumulation was followed by a progressive reduction of the total (cell + medium) prolactin. This result is in agreement with the observed inhibition of de novo synthesis of prolactin and indicates that a degradation process takes place in pituitary cells in culture. In conclusion, the use of vinblastine allows us to demonstrate that the rate of prolactin synthesis is dependent upon the secretory status of the cell.     

Degradation of glucagon receptors by dispase treatment of isolated intact rat hepatocytes

Collagenase-isolated rat hepatocytes were treated with dispase II, a neutral proteolytic enzyme which is often used for the disintegration of neonatal cells. The treatment of hepatocytes with dispase II caused a significant reduction of glucagon binding to the intact cells. The deleterious effect of this enzyme on the specific glucagon binding sites is accompanied by a reduction of the maximum intracellular cyclic AMP production.     

Effect of hormonal and neuronal agents on adenylate cyclase from smooth muscle of the gastric antrum

Smooth muscle adenylate cyclase of a membrane preparation of canine gastric antrum has been characterized, and the effect of hormonal and neuronal agents examined. The enzyme is active in the presence of Mg²⁺ or Mn²⁺, but is inhibited by Ca²⁺. The K_m is 0.5 mM ATP, similar to the K_m of skeletal muscle adenylate cyclase. The enzyme is activated by isoproterenol but not norepinephrine, consistent with a β₂-catecholamine receptor-adenylate cyclase interaction. Secretin activates the enzyme in concentrations as low as 1 · 10^?11 M, while glucagon was effective only at 1 · 10^?6 M. Prostaglandin E₁ and E₂ have a biphasic effect with activation of adenylate cyclase at 1 · 10^?5 M and a small but significant inhibition of enzyme activity at 1 · 10^?11 M.     

Functional reconstitution of rat ovarian LH/hCG receptor into proteoliposomes

Rat ovarian membrane LH/hCG receptor was solubilized in various detergents and reconstituted into proteoliposomes. Upon removal of sodium cholate by active absorption on Bio-Beads SM-2, the functional interaction between receptor and adenylate cyclase was restored. Adenylate cyclase was stimulated by hCG, HCG+GTP or GppNHp and NaF. Reconstituted proteoliposomes bound more ¹²⁵I-hCG (528 fmol/mg protein) than membrane-bound receptors (384 fmol/mg protein). There was no difference, however, in the relative affinity of reconstituted receptor preparations for hCG.